Business
Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities
WILMINGTON, Mass., April 30, 2026--Charles River Laboratories today announced an enhanced In Vitro Fertility (IVF) service bundle designed to accelerate rat-model programs across therapeutics areas, including oncology, neurology, cardiology, and metabolic. By leveraging embryo transfer, cryopreservation, and colony rederivation, teams can rapidly recover lines, expand cohorts, and safeguard critical genotypes—while reducing downtime caused by breeding bottlenecks. This offering pairs dedicated p
About this update from Charles River Laboratories International, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1245,"height":326,"url":"https://media.zenfs.com/en/business-wire.com/f552c0eee7ef553c2bc924dfa4a340e4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/NZ1YOytUQFA99n8vE9JhEg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI1MQ--/https://media.zenfs.com/en/business-wire.com/f552c0eee7ef553c2bc924dfa4a340e4","width":960,"height":251},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/G2Ls_XCyUglE276.wX1pLw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02Mjg-/https://media.zenfs.com/en/business-wire.com/f552c0eee7ef553c2bc924dfa4a340e4","width":1200,"height":314}},"lazy":false},{"type":"text","content":"As the first commercial provider to deliver in vitro fertility services for rat models, Company demonstrates commitment to the 3Rs","length":130,"tagName":"p","attribs":{}},{"type":"text","content":"WILMINGTON, Mass., April 30, 2026--(BUSINESS WIRE)--Charles River Laboratories today announced an enhanced In Vitro Fertility (IVF) service bundle designed to accelerate rat-model programs across therapeutics areas, including oncology, neurology, cardiology, and metabolic. By leveraging embryo transfer, cryopreservation, and colony rederivation, teams can rapidly recover lines, expand cohorts, and safeguard critical genotypes—while reducing downtime caused by breeding bottlenecks. This offering pairs dedicated project management with optional health monitoring and genetic validation to help ensure continuity across discovery, pharmacology, and translational studies. Researchers working in these therapeutic areas can request a streamlined quote and timeline starting this quarter to keep studies on track and data flowing.","length":831,"tagName":"p"},{"type":"text","content":""The introduction of rat IVF is an exciting step forward for Charles River, helping shorten breeding timelines and deliver more consistent, predictable outcomes while making it easier to build healthy animal colonies and keep research moving forward," said Colin Dunn, Corporate Senior Vice President, Global Research Models & Services, Charles River. "Introducing this service provides researchers with a new avenue to advance drug development research and help bring treatment to patients faster, while maintaining industry-leading standar...
More updates from Charles River Laboratories International, Inc.